Platform· Sep 28, 2026
New Homepage: Claim Checks and the Evidence Map
The homepage now shows viral peptide claims next to their evidence grades, plus every compound on one A–D map.
New studies, evidence-grade changes, regulatory shifts, and Research Briefs across the library — in one feed. Educational only; not medical advice.
Platform· Sep 28, 2026
The homepage now shows viral peptide claims next to their evidence grades, plus every compound on one A–D map.
Research brief· Jun 10, 2026
The investigational "triple agonist" posted some of the largest average weight reductions ever reported in an obesity trial — in Phase 2. Here's what that does and doesn't mean.
Research brief· Jun 8, 2026
Novo Nordisk paired a long-acting amylin analog with semaglutide and the market braced for a knockout. The late-2024 topline was more complicated than the headlines. Here is the evidence, graded.
Research brief· Jun 8, 2026
A large US study didn't ask how much coffee people drank — it asked when. The group that kept coffee to the morning showed a lower risk of death than all-day drinkers. The reason that's interesting is also the reason to read it carefully.
Research brief· Jun 8, 2026
A randomized trial in adults over 70 tested vitamin D, omega-3, and a simple home workout against DNA 'aging clocks.' One intervention stood out — and the size of the effect is the part worth reading carefully.
Platform· Apr 12, 2026
Introduced the A–D evidence maturity framework across all compound pages.
Platform· Apr 10, 2026
Added structured status notes and last-reviewed timestamps.
Platform· Apr 9, 2026
Vial+ members can now export compare-table snapshots to CSV.
Platform· Apr 8, 2026
Published initial educational guide set and glossary foundations.
Platform· Apr 6, 2026
Added search, category filter, evidence filter, and popularity/alphabetical sort.
Platform· Apr 5, 2026
Extended launch dataset from six compounds to 30+ tracked profiles.